Furthermore, biomarkers measured in BAL could have a value in diagnosing ILD in IRD in the future [e.g., matrix metallopeptidase 9 (MMP-9) or CCL7] (89, 90). This evidence concerns the gene MMP9 and interstitial lung disease.